GLI
REGN icon

Guardian Life Insurance’s Regeneron Pharmaceuticals REGN Stock Holding History

Guardian Life Insurance’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-233
Closed -$87K – 376
2019
Q4 		$87K Hold
233
– – 0.02% 206
2019
Q3 		$65K Buy
233
+7
+3% +$2.07K 0.01% 267
2019
Q2 		$71K Hold
226
– – 0.01% 246
2019
Q1 		$93K Buy
226
+7
+3% +$2.88K 0.01% 192
2018
Q4 		$82K Buy
219
+6
+3% +$2.2K 0.01% 191
2018
Q3 		$86K Hold
213
– – 0.01% 204
2018
Q2 		$73K Buy
213
+36
+20% +$11.3K 0.01% 214
2018
Q1 		$61K Sell
177
-71
-29% -$24.7K 0.01% 216
2017
Q4 		$93K Buy
248
+74
+43% +$30K 0.02% 208
2017
Q3 		$78K Buy
174
+3
+2% +$1.43K 0.01% 172
2017
Q2 		$84K Sell
171
-119
-41% -$52.1K 0.01% 151
2017
Q1 		$112K Hold
290
– – 0.02% 191
2016
Q4 		$106K Hold
290
– – 0.02% 202
2016
Q3 		$117K Hold
290
– – 0.01% 206
2016
Q2 		$101K Buy
290
+2
+0.7% +$770 0.01% 243
2016
Q1 		$104K Sell
288
-75
-21% -$30.9K 0.01% 231
2015
Q4 		$197K Sell
363
-89
-20% -$48.2K 0.02% 173
2015
Q3 		$210K Buy
452
+122
+37% +$65.5K 0.02% 188
2015
Q2 		$168K Buy
330
+10
+3% +$4.88K 0.01% 195
2015
Q1 		$144K Sell
320
-100
-24% -$42.4K 0.01% 218
2014
Q4 		$172K Hold
420
– – 0.02% 225
2014
Q3 		$151K Sell
420
-21
-5% -$7.04K 0.02% 235
2014
Q2 		$125K Hold
441
– – 0.01% 268
2014
Q1 		$132K Hold
441
– – 0.01% 259
2013
Q4 		$121K Sell
441
-483
-52% -$139K 0.01% 272
2013
Q3 		$289K Buy
924
+6
+0.7% +$1.58K 0.02% 231
2013
Q2 		$206K Buy
+918
New +$214K 0.02% 283

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Guardian Life Insurance's REGN Position: Q1 2020 in Review

Guardian Life Insurance sold out of Regeneron Pharmaceuticals (REGN) in Q1 2020, closing a stake of 233 shares — an estimated $87K sold.

Guardian Life Insurance first reported a position in REGN in Q2 2013 and held it in 27 quarters. The position peaked at $289K in Q3 2013. 816 funds tracked by Wall St. Rank hold REGN as of Q1 2020.

  • Guardian Life Insurance reported no remaining Regeneron Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Guardian Life Insurance sold 233 Regeneron Pharmaceuticals shares in Q1 2020, an estimated $87K.
  • Guardian Life Insurance first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 27 quarters.
  • Guardian Life Insurance's Regeneron Pharmaceuticals position peaked at $289K in Q3 2013.
  • 816 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.